Abstract
Signet ring cell lymphoma (SRCL) is an exceedingly rare morphologic variant of non-Hodgkin lymphoma (NHL). SRCL has to date been described in majority types of NHL, mostly as single case reports. To systematically study the clinicopathologic features of SRCL, 6 cases from 5 patients, together with clinical information and patient outcome, were reviewed. Immunohistochemical stains (IHC) for CD3, CD5, …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
